Net tangible asset backing of 2.98c. Directors have been buying this year - many.
Singapore based pharmaceuticals....mmm.
The Tibetan Copepr Project and the chaos afterwards might leave room here for an upcoming surprise.
If you have room on your watchlist, I suggest you add it and watch for footprints.
http://www.orchidcapital.net/